TowerBrook Capital Partners in its $8.9 billion acquisition of R1 RCM Inc. with CD&R

On August 1, 2024, R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced that it had entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice, in an all-cash transaction with an enterprise value of approximately $8.9 billion.

Wachtell, Lipton, Rosen & Katz is serving as legal counsel to TowerBrook Capital Partners.